An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer.

MLA

Corredor, Germán, et al. “An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer.” JNCI: Journal of the National Cancer Institute, vol. 114, no. 4, Apr. 2022, pp. 609–17. EBSCOhost, https://doi.org/10.1093/jnci/djab215.

APA

Corredor, G., Toro, P., Koyuncu, C., Lu, C., Buzzy, C., Bera, K., Fu, P., Mehrad, M., Ely, K. A., Mokhtari, M., Yang, K., Chute, D., Adelstein, D. J., Thompson, L. D. R., Bishop, J. A., Faraji, F., Thorstad, W., Castro, P., Sandulache, V., & Koyfman, S. A. (2022). An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer. JNCI: Journal of the National Cancer Institute, 114(4), 609–617. https://doi.org/10.1093/jnci/djab215

Chicago

Corredor, Germán, Paula Toro, Can Koyuncu, Cheng Lu, Christina Buzzy, Kaustav Bera, Pingfu Fu, et al. 2022. “An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer.” JNCI: Journal of the National Cancer Institute 114 (4): 609–17. doi:10.1093/jnci/djab215.